pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-19a |
Genomic Coordinates | chr13: 91350891 - 91350972 |
Synonyms | MIRN19A, hsa-mir-19a, miR-19a, miRNA19A, MIR19A |
Description | Homo sapiens miR-19a stem-loop |
Comment | This sequence maps to chromosome 13 and is named miR-19a precursor-13 in reference . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-19a-5p | ||||||||||||||||||||||||||||||
Sequence | 14| AGUUUUGCAUAGUUGCACUACA |35 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SLC38A7 | ||||||||||||||||||||
Synonyms | SNAT7 | ||||||||||||||||||||
Description | solute carrier family 38 member 7 | ||||||||||||||||||||
Transcript | NM_018231 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SLC38A7 | |||||||||||||||||||||
3'UTR of SLC38A7 (miRNA target sites are highlighted) |
>SLC38A7|NM_018231|3'UTR 1 CCACTGCCTCCCAGGGAACACAAGGCCTTTGCCATTGGTCGCAGGAACCCATCTCTTAGAGCTATGGGGCCATTCTTAGT 81 CCACGATCATTCCAACTGGTGGGATGACATCCGGACATCCTCTTCCAGGGACTGGGGCAAACTCAGGCCCCACACCTCTG 161 GACAGCTCAAATCCAGTCCCCTTCCTGCTCCCCAGTCCTGGCAGTGCCGTGGATGGCGGCAGGAAGTCTCACATCATAGA 241 GGACCCCTCCTCCTCTCCCAGTTCTCAACTTCTCCATGCCTGGAATCCACGGGTGAAGAGAGTCGGTAGATCTCATAAGA 321 AAGAATCCAGTCTGACTTCCCTCTGGAGAATGACTATGGACAGAAGGCCACCATCCTCCACAGAGCACCCTGTCCTGAGT 401 AGGGGTTGTGCTCATTACCCCAGGCCAGTGGTAGCTTCCTCAGGAGCCTGGCCACTTCCAACGGTAGCACTGAAGTCATG 481 CAAATGCATAGTCAGGTAGATTCAGACCTTGTCCACACCTTCCTGGGCAACCCCCACCATGAACCTGTCAGCCTCTTTCC 561 CATAGCTAATAGACATTTCCCAGGCCTTGAGGGGCCCCACCCTGTCTCTTTCATCAAACCTGATGGTCCAGGCTGGGCAT 641 CCCTCTCCTCCTCCATCCCCAGACATCACCAGGTCTAATGTTTACAAACGGTGCCAGCCCGGCTCTGAAGCCAAGGGCCG 721 TCCCGTGCCACGGTGCTGTGAGTATTCCTCCGTTAGCTTTCCCCATAAGGTTGGGAGTATCTGCTTTTGTGTCTGAGATG 801 GGCCCCTCTTTTCAGAGGCCGCAGGGTGGGTGATGGAGAAGGCTGAGAACCTTTCAGACCCTCTGTGTGGGCTGGGCTGG 881 TCAGAATCAGGGTGTACCTCCCCGACACCTTCTTTTTCAGTGATGTTTTCTCTTCTTCCTGCCTTTCCTCTGCCTCCTCC 961 CCTGCCAGCCCTAGCGTGACTACCCAGAGACAAAAAAAAAAAAAAAAAAAAAAGGCAGGGCTGGGCGCAGTGGCTCACGC 1041 CTGTAATCCCAGCACTTTGGGAGGCCAAGGCGGGCAGATGACTTGAGGTCAGGAGTTCGAGACCAGCCTGGCCAACACGG 1121 CAAAACCCCATCTCTACTAAAAATACAAAAAATTAACCGGGCATGGTGGCGGGCACCTGTAATCCCAGCTACTTGGGAGG 1201 CTGAGGCAGCAGAGCCGCTTAAACCCAGGAGGCAGAGACTGCAATGAGCTGAGATCGTGCCATTGCACTCCAGCTTGGGC 1281 AACAAGAGTGAAACTTCATCTCAAAAAAACAGAAACAAACAAAAAGGCAGCTGGGTTGTCACTGATGGGCAGCATTTGAG 1361 CCTGCCACACTGGCCTGGAAGTTTCCCTTCCAGTCTGGATTTTGTCTGCTCCTTCCTTCCCCCTCACCCCGTTACCTCTT 1441 CACCTCCCATCTCACTTCACTGTGTAGCTCAGTCTCTCCCACGCACATAATTGGGGACAGTGGGGGCTCTCTTACCAGCC 1521 TCCTCAGCAACGCACGTCCATCAGGCCTGGCCTCAGTGGCCAGCCACATTGATGTCACACTGGAATTGTTACCCCAGAGA 1601 GGGCGAAGAGATAGGCTATCTCCCCACCTCCCACCCTACTCCCCACTATATTCCCGTTTTGACCACCTCAGCCCCTCAGC 1681 TGCCCCCTCTCACTTTGGCCAATCCCAGGCACCAATCAGACTTCCTCCTCCACCTGGAGCCCCTAGCATTTCCTTGTCCC 1761 CTCTTCCCCAAAACCTCTGTAAAGGGTACGAGAGGGACCCCCTGCCGAGCCGCCCGCCACTCAGGGCAGTCCGATCTAAG 1841 AAGCAGAAGCTGGTTGGAGGCTGGCTGGGCCTCTGTCCAGTCCCCAGATGGATAAACTGCCTTTTCTCACATCCCCTCTT 1921 GGTGCCTGATCTTCTCTGCCCCCGGGGCCAGACCCACTGTGCTGTTTTCTGTCAGTCTGTGGCACAGCACCAAGCTCTGC 2001 CAGCACCAGTCCCTGACAGGGCTAGGAGGACAGCCTGGTCAGCAGGGCTGCAGTCCCCCAGTGCCGTGTTTCGGGGGTCA 2081 AGGGATGTAAGTGGAGTCATTGCACAGAGACAGACCAGTCAGGAGAAGGAGCTGGAATCTGGCCTCTTGTCCTAACCTCA 2161 GGAGCCCCCTCCCATCCTCTCCCCACCCTCCCTATCGGGGTACTTCACTGTTTCTTTTCTACTTGTGTATACTCGAGAAA 2241 GGGAAGATGGTTAATAAAAGGGATTTGTGCTGCTGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 55238.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000570101.1 | 3UTR | UGGCCAACACGGCAAAACCCCAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
92 hsa-miR-19a-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038980 | WDR96 | cilia and flagella associated protein 43 | 1 | 1 | ||||||||
MIRT063864 | RASSF8 | Ras association domain family member 8 | 2 | 6 | ||||||||
MIRT077656 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT078461 | MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 2 | 2 | ||||||||
MIRT095248 | FAM13B | family with sequence similarity 13 member B | 2 | 2 | ||||||||
MIRT109490 | KLHL15 | kelch like family member 15 | 2 | 6 | ||||||||
MIRT155378 | CCNT2 | cyclin T2 | 2 | 2 | ||||||||
MIRT163208 | EDEM1 | ER degradation enhancing alpha-mannosidase like protein 1 | 2 | 2 | ||||||||
MIRT188326 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT204723 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | 4 | ||||||||
MIRT236399 | HMGXB4 | HMG-box containing 4 | 2 | 2 | ||||||||
MIRT237114 | P2RY1 | purinergic receptor P2Y1 | 2 | 5 | ||||||||
MIRT286942 | SOCS7 | suppressor of cytokine signaling 7 | 2 | 2 | ||||||||
MIRT442523 | MOB3B | MOB kinase activator 3B | 2 | 2 | ||||||||
MIRT473428 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT476783 | FOS | Fos proto-oncogene, AP-1 transcription factor subunit | 2 | 2 | ||||||||
MIRT476942 | FAM83G | family with sequence similarity 83 member G | 2 | 2 | ||||||||
MIRT480184 | CALM2 | calmodulin 2 | 2 | 6 | ||||||||
MIRT489620 | ZNF384 | zinc finger protein 384 | 2 | 2 | ||||||||
MIRT492246 | SLC39A9 | solute carrier family 39 member 9 | 2 | 2 | ||||||||
MIRT492422 | RGL2 | ral guanine nucleotide dissociation stimulator like 2 | 2 | 2 | ||||||||
MIRT494860 | ZNF99 | zinc finger protein 99 | 2 | 2 | ||||||||
MIRT497001 | SNAP25 | synaptosome associated protein 25 | 2 | 2 | ||||||||
MIRT501973 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT504917 | CD38 | CD38 molecule | 2 | 4 | ||||||||
MIRT507019 | HMGA2 | high mobility group AT-hook 2 | 2 | 6 | ||||||||
MIRT510820 | SBNO1 | strawberry notch homolog 1 | 2 | 4 | ||||||||
MIRT514166 | PGPEP1 | pyroglutamyl-peptidase I | 2 | 2 | ||||||||
MIRT514328 | PSMG2 | proteasome assembly chaperone 2 | 2 | 4 | ||||||||
MIRT514429 | SLC38A7 | solute carrier family 38 member 7 | 2 | 2 | ||||||||
MIRT514537 | ESR2 | estrogen receptor 2 | 2 | 2 | ||||||||
MIRT516117 | SRPX2 | sushi repeat containing protein, X-linked 2 | 2 | 4 | ||||||||
MIRT517759 | ZNF366 | zinc finger protein 366 | 2 | 4 | ||||||||
MIRT518495 | FAM161B | family with sequence similarity 161 member B | 2 | 4 | ||||||||
MIRT518512 | CASP10 | caspase 10 | 2 | 2 | ||||||||
MIRT518561 | GDPD1 | glycerophosphodiester phosphodiesterase domain containing 1 | 2 | 2 | ||||||||
MIRT518641 | NOM1 | nucleolar protein with MIF4G domain 1 | 2 | 2 | ||||||||
MIRT518729 | ABCG8 | ATP binding cassette subfamily G member 8 | 2 | 2 | ||||||||
MIRT523565 | GGCX | gamma-glutamyl carboxylase | 2 | 4 | ||||||||
MIRT526523 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT530254 | ZNF620 | zinc finger protein 620 | 2 | 2 | ||||||||
MIRT531658 | ZFP14 | ZFP14 zinc finger protein | 2 | 2 | ||||||||
MIRT532699 | TCN2 | transcobalamin 2 | 2 | 4 | ||||||||
MIRT534019 | STXBP4 | syntaxin binding protein 4 | 2 | 2 | ||||||||
MIRT535748 | MYO10 | myosin X | 2 | 4 | ||||||||
MIRT544509 | GTF2E2 | general transcription factor IIE subunit 2 | 2 | 2 | ||||||||
MIRT546758 | RLIM | ring finger protein, LIM domain interacting | 2 | 2 | ||||||||
MIRT547929 | HNRNPR | heterogeneous nuclear ribonucleoprotein R | 2 | 2 | ||||||||
MIRT550130 | ZNF138 | zinc finger protein 138 | 2 | 2 | ||||||||
MIRT551763 | MED21 | mediator complex subunit 21 | 2 | 2 | ||||||||
MIRT557727 | FYCO1 | FYVE and coiled-coil domain containing 1 | 2 | 2 | ||||||||
MIRT558924 | CBX1 | chromobox 1 | 2 | 2 | ||||||||
MIRT562466 | CORO1C | coronin 1C | 2 | 2 | ||||||||
MIRT562759 | ZNF846 | zinc finger protein 846 | 2 | 2 | ||||||||
MIRT563061 | ZNF28 | zinc finger protein 28 | 2 | 2 | ||||||||
MIRT563336 | RPLP0 | ribosomal protein lateral stalk subunit P0 | 2 | 2 | ||||||||
MIRT569170 | DMD | dystrophin | 2 | 2 | ||||||||
MIRT573256 | TNFAIP6 | TNF alpha induced protein 6 | 2 | 2 | ||||||||
MIRT575057 | P2ry1 | purinergic receptor P2Y, G-protein coupled 1 | 2 | 4 | ||||||||
MIRT575360 | Zxda | zinc finger, X-linked, duplicated A | 2 | 2 | ||||||||
MIRT613233 | CCDC39 | coiled-coil domain containing 39 | 2 | 2 | ||||||||
MIRT613347 | ADRBK2 | G protein-coupled receptor kinase 3 | 2 | 6 | ||||||||
MIRT613952 | TMEM59 | transmembrane protein 59 | 2 | 2 | ||||||||
MIRT615488 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT618710 | ESD | esterase D | 2 | 2 | ||||||||
MIRT630609 | ARHGAP1 | Rho GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT630619 | CXCR6 | C-X-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT630631 | IMPAD1 | inositol monophosphatase domain containing 1 | 2 | 2 | ||||||||
MIRT630674 | KLF7 | Kruppel like factor 7 | 2 | 2 | ||||||||
MIRT630746 | COG6 | component of oligomeric golgi complex 6 | 2 | 2 | ||||||||
MIRT636853 | ZSCAN2 | zinc finger and SCAN domain containing 2 | 2 | 2 | ||||||||
MIRT638642 | GPATCH8 | G-patch domain containing 8 | 2 | 2 | ||||||||
MIRT639106 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | 2 | 2 | ||||||||
MIRT639422 | PKP1 | plakophilin 1 | 2 | 2 | ||||||||
MIRT640187 | ABCC12 | ATP binding cassette subfamily C member 12 | 2 | 2 | ||||||||
MIRT641757 | SF3A1 | splicing factor 3a subunit 1 | 2 | 2 | ||||||||
MIRT666577 | RHOBTB3 | Rho related BTB domain containing 3 | 2 | 2 | ||||||||
MIRT672166 | FANCF | Fanconi anemia complementation group F | 2 | 2 | ||||||||
MIRT688345 | ETS1 | ETS proto-oncogene 1, transcription factor | 2 | 2 | ||||||||
MIRT690120 | ZFAND1 | zinc finger AN1-type containing 1 | 2 | 2 | ||||||||
MIRT696939 | CERK | ceramide kinase | 2 | 2 | ||||||||
MIRT701361 | NR4A3 | nuclear receptor subfamily 4 group A member 3 | 2 | 2 | ||||||||
MIRT703288 | GID4 | GID complex subunit 4 homolog | 2 | 2 | ||||||||
MIRT709146 | ZNF799 | zinc finger protein 799 | 2 | 2 | ||||||||
MIRT710848 | FAM210A | family with sequence similarity 210 member A | 2 | 2 | ||||||||
MIRT712621 | GTF2H5 | general transcription factor IIH subunit 5 | 2 | 2 | ||||||||
MIRT714591 | CMBL | carboxymethylenebutenolidase homolog | 2 | 2 | ||||||||
MIRT716909 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT721165 | FAM200B | family with sequence similarity 200 member B | 2 | 2 | ||||||||
MIRT722404 | BCAS2 | BCAS2, pre-mRNA processing factor | 2 | 2 | ||||||||
MIRT722517 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT724599 | AP3B1 | adaptor related protein complex 3 beta 1 subunit | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|